Conversion to sirolimus therapy in kidney transplant recipients with new onset diabetes mellitus after transplantation

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Veroux, Massimiliano ^a   Tallarita, Tiziano ^a   Corona, Daniela ^a   Sinagra, Nunziata ^a   Giaquinta, Alessia ^a   Zerbo, Domenico ^a   Guerrieri, Carmela ^a   D'Assoro, Antonino ^b   Cimino, Sebastiano ^a   Veroux, Pierfrancesco ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS; CALCINEURIN; CALCINEURIN INHIBITOR; ENZYME INHIBITOR; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; BLOOD; DRUG EFFECTS; GRAFT REJECTION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; DRUG ANTAGONISM; DRUG EFFECT;

ADULT; CALCINEURIN; CALCINEURIN INHIBITORS; CREATININE; DIABETES MELLITUS; DRUG SUBSTITUTION; ENZYME INHIBITORS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SIROLIMUS;

EID: 84878647728     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/496974     Document Type: Article

References (60)

1. Kasiske B. L., Snyder J. J., Gilbertson D., Matas A. J., Diabetes mellitus after kidney transplantation in the United States. American Journal of Transplantation 2003 3 2 178 185 2-s2.0-0037297155 10.1034/j.1600-6143.2003. 00010.x (Pubitemid 36323115)
2. Hariharan S., Johnson C. P., Bresnahan B. A., Taranto S. E., McIntosh M. J., Stablein D., Improved graft survival after renal transplantation in the United States, 1988 to 1996. The New England Journal of Medicine 2000 342 9 605 612 2-s2.0-0034594881 10.1056/NEJM200003023420901 (Pubitemid 30118412)
3. Sulanc E., Lane J. T., Puumala S. E., Groggel G. C., Wrenshall L. E., Stevens R. B., New-onset diabetes after kidney transplantation: an application of 2003 International Guidelines. Transplantation 2005 80 7 945 952 2-s2.0-27644497091 10.1097/01.TP.0000176482.63122.03 (Pubitemid 41552891)
4. De Pasquale C., Pistorio M. L., Veroux P., Giuffrida G., Sinagra N., Ekser B., Zerbo D., Corona D., Giaquinta A., Veroux M., Quality of life in kidney transplantation from marginal donors. Transplantation Proceedings 2011 43 4 1045 1047 2-s2.0-79957604370 10.1016/j.transproceed.2011.01.156
5. Veroux M., Corona D., Veroux P., Kidney transplantation: future challenges. Minerva Chirurgica 2009 64 1 75 100 2-s2.0-67650254140
6. Meier-Kriesche H. U., Schold J. D., Srinivas T. R., Kaplan B., Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. American Journal of Transplantation 2004 4 3 378 383 2-s2.0-1442338509 10.1111/j.1600-6143.2004.00332.x (Pubitemid 38282293)
7. Shah T., Kasravi A., Huang E., Hayashi R., Young B., Cho Y. W., Bunnapradist S., Risk factors for development of new-onset diabetes mellitus after kidney transplantation. Transplantation 2006 82 12 1673 1676 2-s2.0-33845935691 10.1097/01.tp.0000250756.66348.9a (Pubitemid 46035650)
8. Cosio F. G., Pesavento T. E., Kim S., Osei K., Henry M., Ferguson R. M., Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney International 2002 62 4 1440 1446 2-s2.0-0036379686 10.1046/j.1523-1755.2002.00582.x
9. Krentz A. J., Wheeler D. C., New-onset diabetes after transplantation: a threat to graft and patient survival. The Lancet 2005 365 9460 640 642 2-s2.0-13844310309 10.1016/S0140-6736(05)17962-8 (Pubitemid 40260875)
10. National Institutes of Health NIoDaDaKD. US Renal Data System USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, http://www.usrds.org/2011/view/v2-07.asp
11. Hjelmesæth J., Hartmann A., Leivestad T., Holdaas H., Sagedal S., Olstad M., Jenssen T., The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney International 2006 69 3 588 595 2-s2.0-31544450765 10.1038/sj.ki.5000116 (Pubitemid 43164454)
12. Israni A. K., Snyder J. J., Skeans M. A., Kasiske B. L., Clinical diagnosis of metabolic syndrome: predicting new-onset diabetes, coronary heart disease, and allograft failure late after kidney transplantation. Transplant International 2012 25 7 748 757 10.1111/j.1432-2277.2012.01488.x
13. Sharif A., Baboolai K., Complications associated with new-onset diabetes after kidney transplantation. Nature Reviews Nephrology 2011 8 1 34 42
14. Valderhaug T. G., Hjelmesaeth J., Hartmann A., The association of early post-transplant glucose levels with long-term mortality. Diabetologia 2011 54 6 1341 1349
15. Cole E. H., Johnston O., Rose C. L., Gill J. S., Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival. Clinical Journal of the American Society of Nephrology 2008 3 3 814 821 2-s2.0-44649146622 10.2215/CJN.04681107
16. Valderhaug T. G., Hjelmesaeth J., Jenssen T., Røislien J., Leivestad T., Hartmann A., Early posttransplantation hyperglycemia in kidney transplant recipients is associated with overall long-term graft losses. Transplantation 2012 94 7 714 720
17. Matas A. J., Gillingham K. J., Humar A., Ibrahim H. N., Payne W. D., Gruessner R. W. G., Dunn T. B., Sutherland D. E. R., Najarian J. S., Kandaswamy R., Posttransplant diabetes mellitus and acute rejection: impact on kidney transplant outcome. Transplantation 2008 85 3 338 343 2-s2.0-40049083710 10.1097/TP.0b013e318160ee42 (Pubitemid 351322756)
18. Pietrzak-Nowacka M., Safranow K., Dziewanowski K., Debska-Slizień A., Głyda M., Gołembiewska E., Jankowska M., Nowosiad M., Rutkowski B., Ciechanowski K., Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation. Annales Academiae Medicae Stetinensis 2008 54 1 41 48 2-s2.0-60849093782
19. Woodward R. S., Schnitzler M. A., Baty J., Lowell J. A., Lopez-Rocafort L., Haider S., Woodworth T. G., Brenna D. C., Incidence and cost of new onset diabetes mellitus among U.S. Wait-listed and transplanted renal allograft recipients. American Journal of Transplantation 2003 3 5 590 598 2-s2.0-0038075448 10.1034/j.1600-6143.2003.00082.x (Pubitemid 36612842)
20. Kamar N., Mariat C., Delahousse M., Dantal J., Al Najjar A. L., Cassuto E., Lefrançois N., Cointault O., Touchard G., Villemain F., Di Giambattista F., Benhamou P. Y., Diabetes mellitus after kidney transplantation: a French multicentre observational study. Nephrology Dialysis Transplantation 2007 22 7 1986 1993 2-s2.0-34547839646 10.1093/ndt/gfm011 (Pubitemid 47244771)
21. Joss N., Staatz C. E., Thomson A. H., Jardine A. G., Predictors of new onset diabetes after renal transplantation. Clinical Transplantation 2007 21 1 136 143 2-s2.0-33846665132 10.1111/j.1399-0012.2006.00580.x (Pubitemid 46189598)
22. Hamer R. A., Chow C. L., Ong A. C. M., McKane W. S., Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation. Transplantation 2007 83 1 36 40 2-s2.0-33846227952 10.1097/01.tp.0000248759. 37146.3d (Pubitemid 46104968)
23. Fabrizi F., Martin P., Dixit V., Bunnapradist S., Kanwal F., Dulai G., Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies. American Journal of Transplantation 2005 5 10 2433 2440 2-s2.0-33644683298 10.1111/j.1600-6143.2005. 01040.x
24. Sarno G., Muscogiuri G., De Rosa P., New-onset diabetes after kidney transplantation: prevalence, risk factors, and management. Transplantation 2012 93 12 1189 1195 10.1097/TP.0b013e31824db97d
25. Davidson J., Wilkinson A., Dantal J., Dotta F., Haller H., Hernández D., Kasiske B. L., Kiberd B., Krentz A., Legendre C., Marchetti P., Markell M., Van Der Woude F. J., Wheeler D. C., Monaco A. P., Morris P. J., New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 2003 75 10, supplement SS3 SS24 2-s2.0-0037844594
26. Yates C. J., Fourlanos S., Hjelmesaeth J., Colman P. G., Cohney S. J., New-onset diabetes after kidney transplantation-changes and challenges. American Journal of Transplantation: 2012 12 4 820 828
27. Pham P. T., Pham P. M., Pham S. V., Pham P. A., Pham P. C., New onset diabetes after transplantation (NODAT): an overview. Diabetes, Metabolic Syndrome and Obesity 2011 4 175 186 10.2147/DMSO.S19027
28. Yao B., Chen X., Shen F. X., The incidence of posttransplantation diabetes mellitus during follow-up in kidney transplant recipients and relationship to Fok1 vitamin D receptor polymorphism. Transplantation Proceedings 2013 45 1 194 196
29. Montori V. M., Basu A., Erwin P. J., Velosa J. A., Gabriel S. E., Kudva Y. C., Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 2002 25 3 583 592 2-s2.0-0036511287
30. Kreis H., Oberbauer R., Campistol J. M., Rapamune maintenance regimen trial: long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal. Journal of the American Society of Nephrology 2004 15 3 809 817 (Pubitemid 38294812)
31. Mota A., Arias M., Taskinen E. I., Paavonen T., Brault Y., Legendre C., Claesson K., Castagneto M., Campistol J. M., Hutchison B., Burke J. T., Yilmaz S., Häyry P., Neylan J. F., Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years. American Journal of Transplantation 2004 4 6 953 961 2-s2.0-2942534405 10.1111/j.1600-6143.2004.00446.x (Pubitemid 38745595)
32. Kahan B. D., Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Lancet 2000 356 9225 194 202 2-s2.0-0034661736 (Pubitemid 30446974)
33. Johnson R. W. G., Kreis H., Oberbauer R., Brattstrom C., Claesson K., Eris J., Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. Transplantation 2001 72 5 777 786 2-s2.0-0035884710 (Pubitemid 32879845)
34. World Health Organization, Diabetes Mellitus. 1985 727 Geneva, Switzerland WHO
35. Nagaraja P., Ravindran V., Morris-Stiff G., Baboolai K., Role of insulin resistance indices in predicting new-onset diabetes mellitus after kidney transplantation. Transplant International 2013 26 3 273 280
36. Pham P. T., Edling K. L., Chakkera H. A., Pham P. C., Pham P. M., Screening strategies and predictive diagnostic tools for the development of new-onset diabetes mellitus after transplantation: an overview. Diabetes, Metabolic Syndrome and Obesity 2012 5 379 387
37. Zelle D. M., Corpeleijn E., Deinum J., Pancreatic β -cell dysfunction and risk of new-onset diabetes after kidney transplantation. Diabetes Care 2013 10.2337/dc12-1894
38. Wilkinson A., Davidson J., Dotta F., Guidelines for the management of new-onset diabetes after transplantation. Clinical Transplantation 2005 19 3 291 298 (Pubitemid 40711959)
39. Hoitsma A. J., Hilbrands L. B., Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression. Clinical Transplantation 2006 20 5 659 664 2-s2.0-33748665445 10.1111/j.1399-0012.2006.00535.x (Pubitemid 44383414)
40. Van Hooff J. P., Christiaans M. H. L., van Duijnhoven E. M., Evaluating mechanisms of post-transplant diabetes mellitus. Nephrology Dialysis Transplantation 2004 19 supplement 6 vi8 vi12 2-s2.0-11244340690 10.1093/ndt/gfh1063 (Pubitemid 40057665)
41. Cole E., Landsberg D., Russell D., Zaltzman J., Kiberd B., Caravaggio C., Vasquez A. R., Halloran P., A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation 2001 72 5 845 850 2-s2.0-0035884533 (Pubitemid 32879856)
42. Rostaing L., Cantarovich D., Mourad G., Budde K., Rigotti P., Mariat C., Margreiter R., Capdevilla L., Lang P., Vialtel P., Ortuño-Mirete J., Charpentier B., Legendre C., Sanchez-Plumed J., Oppenheimer F., Kessler M., Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation 2005 79 7 807 814 2-s2.0-20244371042 10.1097/01.TP.0000154915.20524.0A (Pubitemid 40546200)
43. Walczak D. A., Calvert D., Jarzembowski T. M., Testa G., Sankary H. N., Thielke J., Oberholzer J., Benedetti E., Increased risk of post-transplant diabetes mellitus despite early steroid discontinuation in Hispanic kidney transplant recipients. Clinical Transplantation 2005 19 4 527 531 2-s2.0-22244452014 10.1111/j.1399-0012.2005.00383.x (Pubitemid 40990665)
44. Luan F. L., Steffick D. E., Ojo A. O., New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression. Transplantation 2011 91 3 334 341 2-s2.0-79951510347 10.1097/TP.0b013e318203c25f
45. Van Duijnhoven E. M., Christiaans M. H. L., Boots J. M. M., Nieman F. H. M., Wolffenbuttel B. H. R., Van Hooff J. P., Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression. Journal of the American Society of Nephrology 2002 13 1 213 220 2-s2.0-0036139867 (Pubitemid 34042030)
46. Ghisdal L., Bouchta N. B., Broeders N., Crenier L., Hoang A. D., Abramowicz D., Wissing K. M., Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature. Transplant International 2008 21 2 146 151 2-s2.0-38049161874 10.1111/j.1432-2277.2007.00589.x
47. Veroux M., Tallarita T., Corona D., D'Assoro A., Gurrieri C., Veroux P., Sirolimus in solid organ transplantation: current therapies and new frontiers. Immunotherapy 2011 3 12 1487 1497
48. Johnston O., Rose C. L., Webster A. C., Gill J. S., Sirolimus is associated with new-onset diabetes in Kidney transplant recipients. Journal of the American Society of Nephrology 2008 19 7 1411 1418 2-s2.0-48149112155 10.1681/ASN.2007111202
49. Gyurus E., Kaposztas Z., Kahan B. D., Sirolimus therapy predisposes to new-onset diabetes mellitus after renal transplantation: a long-term analysis of various treatment regimens. Transplantation Proceedings 2011 43 5 1583 1592 2-s2.0-79959483515 10.1016/j.transproceed.2011.05.001
50. Shivaswamy V., McClure M., Passer J., Frahm C., Ochsner L., Erickson J., Bennett R. G., Hamel F. G., Larsen J. L., Hyperglycemia induced by tacrolimus and sirolimus is reversible in normal sprague-dawley rats. Endocrine 2010 37 3 489 496 2-s2.0-77952090325 10.1007/s12020-010-9332-6
51. Pereira M. J., Palming J., Rizell M., mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes. Molecular and Cellular Endocrinology 2012 355 1 96 105
52. Teutonico A., Schena P. F., Di Paolo S., Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus. Journal of the American Society of Nephrology 2005 16 10 3128 3135 2-s2.0-32844474879 10.1681/ASN.2005050487 (Pubitemid 44743511)
53. Veroux M., Corona D., Giuffrida G., Gagliano M., Sorbello M., Virgilio C., Tallarita T., Zerbo D., Giaquinta A., Fiamingo P., Macarone M., Li Volti G., Caglia P., Veroux P., New-onset diabetes mellitus after kidney transplantation: the role of immunosuppression. Transplantation Proceedings 2008 40 6 1885 1887 2-s2.0-48049110764 10.1016/j.transproceed.2008.06.005
54. Veroux M., Corona D., Giuffrida G., Gagliano M., Vizcarra D., Tallarita T., Zerbo D., Giaquinta A., Sorbello M., MacArone M., Veroux P., Sirolimus-based immunosuppression in kidney transplantation for type 2 diabetic nephropathy. Urologia Internationalis 2010 84 3 301 304 2-s2.0-77951117137 10.1159/000288232
55. Batista F., Auyanet I., Torregrosa J. V., Oppenheimer F., Long-term follow up after conversion to cyclosporine in renal transplant patients with new-onset diabetes mellitus after transplantation. Transplantation Proceedings 2012 44 9 2582 2584
56. Kuo H. T., Sampaio M. S., Vincenti F., Bunnapradist S., Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and acute rejection with transplant outcomes: an analysis of the organ procurement and transplant network/united network for organ sharing (OPTN/UNOS) database. American Journal of Kidney Diseases 2010 56 6 1127 1139 2-s2.0-78649431438 10.1053/j.ajkd.2010.06.027
57. Veroux M., Grosso G., Ekser B., Corona D., Giaquinta A., Veroux P., Impact of conversion to a once daily tacrolimus-based regimen in kidney transplant recipients with gastrointestinal complications. Transplantation 2012 93 9 895 899
58. Vodenik B., Rovira J., Campistol J. M., Mammalian target of rapamycin and diabetes: what does the current evidence tell us? Transplantation Proceedings 2009 41 6, supplement S31 S38 2-s2.0-67949084959 10.1016/j.transproceed.2009.06. 159
59. Wittmann S., Daniel C., Stief A., Vogelbacher R., Amann K., Hugo C., Long-term treatment of sirolimus but not cyclosporine ameliorates diabetic nephropathy in the rat. Transplantation 2009 87 9 1290 1299 2-s2.0-67649616517 10.1097/TP.0b013e3181a192bd
60. Piemonti L., Maffi P., Monti L., Lampasona V., Perseghin G., Magistretti P., Secchi A., Bonifacio E., Beta cell function during rapamycin monotherapy in long-term type 1 diabetes. Diabetologia 2011 54 2 433 439 2-s2.0-78951480815 10.1007/s00125-010-1959-6